Expertise Across Diverse Clinical Research Studies
Delivering specialized clinical research solutions across pharmaceutical, biotechnology, vaccine and medical device development programs.
Fixed Dose Combination
Supporting fixed dose combination studies with robust clinical planning, regulatory compliance and scientific expertise.
Vaccine Study
Managing vaccine clinical studies focused on safety, immunogenicity and effective trial execution.
Medical Device
Providing clinical evaluation and research support for innovative medical devices and healthcare technologies.
Biosimilar Study
Supporting biosimilar development through compliant clinical research and scientific assessment.
Clinical Suitability Of Combination Products
Advancing Fixed Dose Combination studies through scientific expertise, regulatory strategy and evidence-based clinical research.
Regulatory & Scientific Expertise
We provide strategic regulatory support to help address FDC-specific requirements, including combination rationale, dose justification, safety assessment, and clinical evidence generation.
Our multidisciplinary experts ensure that combination products are evaluated through robust clinical methodologies while maintaining compliance with global regulatory expectations.
Scientific Confidence
Supporting successful FDC development with regulatory insight, clinical expertise and quality-driven execution.
Therapeutic Area Experience
Small Molecule & Fixed Dose Combination Studies
| Sr. No | Indication | Study Population | Phase of Study | No. Of Site |
|---|---|---|---|---|
| 1 | Covid-19 | 400 | II & III | 6 |
| 2 | Osteoarthritis | 350 | III | 4 |
| 3 | Rheumatoid Arthritis | 210 | III & IV | 8 |
| 4 | Major Depressive Disorder | 80 | III | 3 |
| 5 | Type 2 Diabetes | 180 | II, III & IV | 9 |
| 6 | Anesthesia | 90 | III | 6 |
| 7 | Covid-19 (Ayush) | 350 | II | 8 |
| 8 | Psychiatry | 70 | II | 4 |
| 9 | Acne Vulgaris | 300 | III & IV | 7 |
Advancing Vaccine Development Through Clinical Excellence
Comprehensive clinical research support for vaccine development programs from early development to regulatory approval and post-marketing surveillance.
Comprehensive Vaccine Clinical Research Support
Our CRO provides comprehensive clinical research support for vaccine development programs, helping pharmaceutical, biotechnology, and healthcare organizations advance innovative vaccines from early development through regulatory approval and post-marketing surveillance.
With expertise in vaccine clinical trial design, operational execution, immunogenicity assessment, safety monitoring, and regulatory compliance, our team supports sponsors in generating high-quality clinical evidence while ensuring participant safety and study integrity.
Vaccine Research Expertise
Delivering reliable vaccine clinical trial solutions with scientific accuracy, regulatory compliance and patient safety.
Our Vaccine Study Experience
End-to-End Vaccine Development Support
Supporting vaccine programs across multiple development stages including early-phase studies, proof-of-concept trials, pivotal Phase III studies and post-approval surveillance programs.
Clinical Trial Design & Management
Protocol development, feasibility assessment, site selection, patient recruitment, trial monitoring and study close-out support.
Immunogenicity & Safety Assessment
Evaluation of immune response, safety profiles, adverse events and benefit-risk assessment across diverse populations.
Infectious Disease Expertise
Our vaccine research experience includes clinical studies supporting infectious disease prevention and vaccine development programs.
Vaccine Study Experience
| Sr. No | Indication | Study Population | Phase of Study | No. Of Site |
|---|---|---|---|---|
| 1 | Hepatitis B | 300 | II | 6 |
| 2 | Hepatitis A | 400 | III | 6 |
| 3 | Covid-19 | 400 | II | 7 |
Advancing Medical Device Innovation Through Clinical Evidence
Comprehensive clinical research solutions supporting medical device safety, performance, usability and regulatory success.
Medical Device Clinical Research Expertise
At Zeyos Health Technologies Pvt. Ltd., we provide comprehensive clinical research solutions for medical device manufacturers, innovators and healthcare companies.
Our experience in medical device studies supports the generation of high-quality clinical evidence required to evaluate the safety, performance, usability and clinical effectiveness of medical devices across different stages of development.
From early feasibility studies to post-market clinical follow-up, our experienced team supports the complete clinical research lifecycle with a strong focus on patient safety, data integrity, regulatory compliance and quality-driven study execution.
Medical Device Research Excellence
Supporting innovative healthcare technologies with scientific expertise, regulatory compliance and patient-focused clinical research.
Our Medical Device Study Capabilities
Early Feasibility Studies
First-in-Human Studies
Pilot & Pivotal Clinical Studies
Clinical Performance Studies
Safety & Effectiveness Studies
Comparative Studies
Post-Market Clinical Follow-Up (PMCF)
Post-Market Surveillance (PMS)
Registry & Real-World Evidence Studies
Usability & Human Factors Studies
Diagnostic & IVD Studies
Clinical Evaluation Support
Medical Device Categories
Our clinical research experience may support studies involving:
Medical Devices
In-Vitro Diagnostic Devices (IVDs)
Digital Health Technologies
Software as Medical Device
Diagnostic Equipment
Surgical Devices
Orthopaedic Devices
Cardiovascular Devices
Our Experience
| Sr. No | Indication | Study Population | No. Of Site |
|---|---|---|---|
| 1 | Polymer Bandage | 50 | 1 |
| 2 | Respiratory Device | 40 | 2 |
| 3 | Hemoperfusion | 40 | 1 |
Advancing Biosimilar Development Through Clinical Excellence
Scientifically rigorous and regulatory-compliant clinical research solutions for successful biosimilar development programs.
Biosimilar Clinical Research Expertise
At Zeyos Health Technologies Pvt. Ltd., we support the development of biosimilar products through scientifically rigorous, quality-driven and regulatory-compliant clinical research solutions.
Our experience in biosimilar studies enables sponsors to generate reliable clinical evidence for demonstrating similarity to reference biologic products in terms of pharmacokinetics, pharmacodynamics, safety, tolerability, immunogenicity and clinical outcomes.
Our multidisciplinary team supports sponsors across the clinical development lifecycle—from study planning and protocol development to clinical execution, data management, statistical analysis, medical writing and regulatory documentation.
Biosimilar Research Excellence
Supporting biologic innovation through robust clinical evidence generation, scientific expertise and regulatory compliance.
Why Partner With Us for Biosimilar Studies?
Biologics & Biosimilar Experience
PK/PD & Immunogenicity Expertise
Clinical Operations & Investigator Coordination
Patient Recruitment & Retention Strategies
Quality Data Management & Biostatistics
GCP Compliant Study Execution
Regulatory & Medical Writing Support
Flexible Solutions for Biotech Companies
Our Biosimilar Study Experience
| Sr. No | Indication | Study Population | Phase of Study | No. Of Site |
|---|---|---|---|---|
| 1 | Rheumatoid Arthritis | 200 | II & III | 7 |
| 2 | Psoriasis | 180 | III | 6 |
| 3 | Psoriatic Arthritis | 150 | III | 6 |
| 4 | Non-Small Cell Lung Cancer | 120 | II | 9 |
| 5 | Cervical Cancer | 80 | III | 8 |
| 6 | Metastatic Renal Cell Carcinoma | 80 | III | 9 |
| 7 | Metastatic Breast Cancer | 90 | III | 10 |
| 8 | Severe Cases of COVID-19 | 280 | II, III & IV | 8 |
| 9 | Metastatic Colorectal Cancer | 90 | III | 9 |
| 10 | Diabetic Nephropathy | 80 | III | 7 |
| 11 | Acute Schizophrenia | 160 | II | 6 |
| 12 | Chronic Kidney Disease | 110 | III | 9 |
| 13 | Hernia Study - General Surgery | 70 | III | 7 |
| 14 | Medullary Thyroid Cancer | 90 | III | 9 |